-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RuesOgaxvcsDA4HjZ2eInYp5m3xiA3ceimC+tWGJX3eGjmAx/grYgcdmALs7l4LN dCeGJAi1qghe3RCmt2WKWg== 0000891618-02-002003.txt : 20020430 0000891618-02-002003.hdr.sgml : 20020430 ACCESSION NUMBER: 0000891618-02-002003 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020429 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-61317 FILM NUMBER: 02623600 BUSINESS ADDRESS: STREET 1: 22215 26TH AVENUE S E STREET 2: SUITE 3000 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254894990 MAIL ADDRESS: STREET 1: 22215 26TH AVENUE S E STREET 2: SUITE 3000 CITY: BOTHELL STATE: WA ZIP: 98021 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GENENTECH INC CENTRAL INDEX KEY: 0000318771 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 942347624 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-225-1000 MAIL ADDRESS: STREET 1: 1 DNA WAY STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 SC 13G/A 1 f81101sc13ga.htm SCHEDULE 13G/A Genentech, Inc. Amendment #3 to Schedule 13G
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. 3)*

Seattle Genetics, Inc.

(Name of Issuer)

Common Stock
(Title of Class of Securities)

812578102

(CUSIP Number)

April 19, 2002

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

[   ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[   ] Rule 13d-1(d)

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

                 
Cusip No   812578102            
1.   Names of Reporting Persons   Genentech, Inc.        
    I.R.S. Identification Nos. of above persons (entities only)   94-2347624        
2.   Check the Appropriate Box if a Member of a Group (See Instructions)   Not Applicable
(a) [   ]
(b) [   ]		        
3.   Sec Use Only            
4.   Citizenship or Place of Organization   Delaware        
                 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

   5. Sole Voting Power
1,663,530
         
6. Shared Voting Power
0
          
7. Sole Dispositive Power
1,663,530
          
8. Shared Dispositive Power
0
          
9.   Aggregate Amount Beneficially Owned By Each Reporting Person
1,663,530
          
10.   Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
Not Applicable 
        
11.   Percent of Class Represented by Amount in Row (9)
5.43%
        
12.   Type of Reporting Person (See Instructions)
CO
          
 
 

 

 

Item 1.

  (a)   Name Issuer
Seattle Genetics, Inc.
 
  (b)   Address of Issuer’s Principal Executive Offices
21823 30th Drive SE, Bothell, Washington 98021

Item 2.

  (a)   Name of Person Filing
Genentech, Inc.
 
  (b)   Address of Principal Business Office, or, if none, Residence
1 DNA Way, South San Francisco, California 94080
 
  (c)   Citizenship
Not Applicable
 
  (d)   Title of Class of Securities
Common Stock
 
  (e)   CUSIP Number
812578102

     
Item 3.   If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
 
    Not applicable

       
  (a)   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o)
 
  (b)   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
 
  (c)   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).
 
  (d)   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
 
  (e)   An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).
 
  (f)   An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F).
 
  (g)   A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G).
 
  (h)   A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813).
 
  (i)   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3).
 
  (j)   Group, in accordance with Section 240.13d-1(b)(l)(ii)(J).

 

 

     
Item 4.   Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

                     
    (a)   Amount beneficially owned:   1,663,530
             
    (b)   Percent of class:   5.43%
             
    (c)   Number of shares as to which the person has:    
             
        (i) Sole power to vote or to direct the vote:   1,663,530
             
        (ii) Shared power to vote or to direct the vote:   0
             
        (iii) Sole power to dispose or to direct the disposition of:   1,663,530
             
        (iv) Shared power to dispose or to direct the disposition of:   0
     
Item 5.   Owernship of Five Percent or Less of a Class


If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following: [   ]

     
Item 6.   Ownership of More than Five Percent on Behalf of Another Person.
 Not Applicable.
   
 Item 7.  
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person.
 Not Applicable.
     
Item 8.   Identification and Classification of Members of the Group
 Not Applicable.
     
Item 9.   Notice of Dissolution of Group
 Not Applicable.
     
Item 10.   Certification

       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

 

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 
GENENTECH, INC.
 
/s/ STEPHEN G. JUELSGAARD
Signature
 
Stephen G. Juelsgaard
Senior Vice President, General Counsel and Secretary
Name/Title
 
April 26, 2002
Date


The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative’s authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001).

  -----END PRIVACY-ENHANCED MESSAGE-----